Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2003

View Archived Issues

Three series of COX-2 inhibitors prepared and tested at GSK

Protection of heart allografts by alpha-MSH in rats

Potential use of early kidney precursors in renal transplantation

Sex differences for NO-induced effects in sickle cell disease

Hemoglobin raffimer in coronary artery bypass graft surgery

Lipid-lowering effects reported for a diet combining soy proteins, plant sterols and viscous fiber

New antitumor agents prepared and tested by French team

Boehringer Ingelheim claims new telomerase inhibitors

Wyeth presents new beta-lactamase inhibitors in recent patent

Orally available carbapenem antibiotics in early development at Kyoto Pharmaceutical

Banyu scientists prepare and test piperidine-based NPY antagonists

New series of antibacterial compounds discovered by Washington U. scientists

CAT and Dyax expand licensing agreement

ABI-007 receives fast track status for metastatic breast cancer

Galenica and Spanish National Center of Biotechnology to develop smallpox subunit vaccine

Novartis and Ivax sign Airmax inhaler agreement for respiratory products

Novartis seeks approval for lower dose of Estalis in Sweden

Ono and GSK sign agreement for Ono-4128

Zavesca marketing approval sought in Israel

Ranexa terminates ventricular tachycardia in preclinical study

Positive phase III results for Enbrel in psoriasis

New title added to the Drug R&D Backgrounders topic list - Bipolar Disorder

Vascular targeting agent ZD-6126 exerts significant antitumor activity at well-tolerated doses

Chiesi's budesonide Modulite pMDI approved in Germany

Biprel launched in Canada for hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...